ArticleNeurology2018
Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis: The MIRROR study.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleNeurology2018
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.